BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24344919)

  • 1. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
    Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
    BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic mechanisms involved in differential MDR1 mRNA expression between gastric and colon cancer cell lines and rationales for clinical chemotherapy.
    Lee TB; Park JH; Min YD; Kim KJ; Choi CH
    BMC Gastroenterol; 2008 Aug; 8():33. PubMed ID: 18673531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
    Shinojima T; Yu Q; Huang SK; Li M; Mizuno R; Liu ET; Hoon DS; Lessard L
    Epigenetics; 2012 Nov; 7(11):1279-89. PubMed ID: 23023649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential.
    Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C
    J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in chromatin structure induced by treatment with 5-Aza-cytidine.
    David GL; Yegnasubramanian S; Kumar A; Marchi VL; De Marzo AM; Lin X; Nelson WG
    Cancer Biol Ther; 2004 Jun; 3(6):540-8. PubMed ID: 15034303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia.
    Paradowska A; Fenic I; Konrad L; Sturm K; Wagenlehner F; Weidner W; Steger K
    Int J Oncol; 2009 Jul; 35(1):87-96. PubMed ID: 19513555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
    Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
    Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
    Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer.
    Luo W; Karpf AR; Deeb KK; Muindi JR; Morrison CD; Johnson CS; Trump DL
    Cancer Res; 2010 Jul; 70(14):5953-62. PubMed ID: 20587525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
    Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
    Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.
    Koch P; Petri M; Paradowska A; Stenzinger A; Sturm K; Steger K; Wimmer M
    Prostate; 2009 Dec; 69(16):1751-62. PubMed ID: 19691131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.
    Huo H; Magro PG; Pietsch EC; Patel BB; Scotto KW
    Cancer Res; 2010 Nov; 70(21):8726-35. PubMed ID: 20861184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas.
    Peng D; Hu TL; Jiang A; Washington MK; Moskaluk CA; Schneider-Stock R; El-Rifai W
    PLoS One; 2011; 6(7):e22009. PubMed ID: 21818286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
    Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
    Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.
    Mishra DK; Chen Z; Wu Y; Sarkissyan M; Koeffler HP; Vadgama JV
    Mol Cancer Ther; 2010 Jan; 9(1):33-45. PubMed ID: 20053773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.